Menu
Home
About Us
Who We Are
Purpose & Values
Board
Partners
Distributors
Compliance
Careers
Technology
Our Solution
Technology Introduction
Platform Technology
Publications
Image Gallery
Webinars
FAQ
Products
Our Products
InVivage
ViewnVivo
Customisation
Pipeline
Investor
Investor Overview
ASX Announcements
Reports
Share Price Information
Financial Calendar
Media Coverage
Sustainability
Share Registry
Investor Alerts
Media
News
Social Media Feed
Contact
Contact
Select Category
Clinical Research
Oral cancer diagnosis and surgical margin
Brain cancer
General surgery
Cervical assessment
Gastrointestinal assessment
Life Sciences Research
Cell viability
Live antibody labelling
Intraoperative surgery and tumour margin delineation
Blood vessel, perfusion, and barrier function
Live microflora imaging
Nano particle and drug delivery
Proof of concept in live models
Recent Posts
Tech Operating at Sharp End of Surgery (The Australian)
Optiscan’s Platform could address Global Pathologist Shortage
‘Diagnose on the spot’: Optiscan’s Platform brings together Surgeons and Pathologists for Better Cancer Outcomes
Optiscan Moves to Stamp Stronger US Footprint
Optiscan on Cusp of Real-Time Cancer Imaging Breakthrough
Archives
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
November 2022
September 2022
February 2022
May 2021
March 2021
January 2021
December 2020
Categories
Announcements
Blood vessel, perfusion, and barrier function
Brain cancer
Broker Research
Cell viability
Cervical assessment
Gastrointestinal assessment
General surgery
Intraoperative surgery and tumour margin delineation
Live antibody labelling
Live microflora imaging
Nano particle and drug delivery
Optiscan news
Oral cancer diagnosis and surgical margin
Proof of concept in live models
Uncategorized
Veterinary
Tech Operating at Sharp End of Surgery (The Australian)
November 27th, 2023 by Andrew Barker
Read More
Optiscan’s Platform could address Global Pathologist Shortage
November 19th, 2023 by Andrew Barker
Read More
‘Diagnose on the spot’: Optiscan’s Platform brings together Surgeons and Pathologists for Better Cancer Outcomes
October 30th, 2023 by Andrew Barker
Read More
Optiscan Moves to Stamp Stronger US Footprint
October 12th, 2023 by Andrew Barker
Read More
Optiscan on Cusp of Real-Time Cancer Imaging Breakthrough
September 19th, 2023 by Andrew Barker
Read More
Nod of approval: Optiscan deal boosts revenue by 66%
September 1st, 2023 by Andrew Barker
Read More
Optiscan Clears Key Telepathology Milestone
August 15th, 2023 by Andrew Barker
Read More
Entitlement Offer Results and Shortfall Announcement
July 13th, 2023 by Andrew Barker
Read More
InVivage study with Melbourne Dental School published in Frontiers of Oncology
July 5th, 2023 by Andrew Barker
Read More
Optiscan on Mission to Revolutionise Medical Imaging
June 1st, 2023 by Andrew Barker
Read More
Optiscan Launches Entitlement Offer to raise $16.7M to Fund Strategic Portfolio Expansion
May 30th, 2023 by Andrew Barker
Read More
Optiscan Imaging Featured in Twin Cities Business
April 5th, 2023 by Andrew Barker
Read More
Optiscan Imaging Featured in Australian Financial Review
March 3rd, 2023 by Andrew Barker
Read More
Dr. Camile Farah talks with Matt Birney on 2GB Sydney Radio
February 6th, 2023 by Andrew Barker
Read More
Optiscan Launches World Cancer Day 2023 Awareness Initiative
February 4th, 2023 by Andrew Barker
Read More
Dr. Camile Farah talks with Matt Birney on 6PR Perth Radio
February 3rd, 2023 by Andrew Barker
Read More
Dr. Camile Farah talks with Matt Birney on 3AW 693 Melbourne Radio
February 3rd, 2023 by Andrew Barker
Read More
1
Back to All Publications
